|
|
|
Search for: "Centocor"
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
HSMN NewsFeed,
23 Jun 2010:
Biopharmaceuticals, Personnel
[Spectrum Pharmaceuticals]
|
HEALTHPOINT, Ltd. Announces New Vice President, Sales Brad Adams
HSMN NewsFeed,
16 Jun 2010:
Biopharmaceuticals, Wound Care, Personnel
[Healthpoint, DFB Pharmaceuticals]
|
POZEN Announces Election of Neal F. Fowler to the Board of Directors
HSMN NewsFeed,
15 Jun 2010:
Biopharmaceuticals, Personnel
[POZEN]
|
Trubion Pharmaceuticals Wins Genentech and Biogen Idec Patent Appeal
HSMN NewsFeed,
3 Jun 2010:
Biopharmaceuticals, Litigation
[Trubion Pharmaceuticals, Genentech, Biogen Idec, CD20, rheumatoid arthritis]
|
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
HSMN NewsFeed,
1 Jun 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Centocor Ortho Biotech, Johnson & Johnson, RespiVert, RV-568, RV-1088]
|
STELARA(TM) Significantly Improves Symptoms of Depression, Anxiety and Health-Related Quality of Life in Patients With Moderate to Severe Psoriasis
HSMN NewsFeed,
19 May 2010:
Biopharmaceuticals, Dermatology
[Janssen-Cilag, STELARA, Black Triangle Drug, ustekinumab, psoriasis]
|
REMICADE(R) Study Results Show Greater Steroid-Free Remission and Mucosal Healing Compared With Conventional Immunomodulator Azathioprine in Treatment of Crohn's Disease
HSMN NewsFeed,
15 Apr 2010:
Biopharmaceuticals, Gastroenterology
[Centocor Ortho Biotech, REMICADE, infliximab, Crohn's disease, Sonic Study]
|
Auxilium Announces Promotion of Benjamin Del Tito Jr., Ph.D. to Executive Vice President, Regulatory Affairs and Project Management
HSMN NewsFeed,
29 Mar 2010:
Biopharmaceuticals, Personnel
[Auxilium Pharmaceuticals]
|
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
HSMN NewsFeed,
15 Mar 2010:
Biopharmaceuticals, Diagnostics, Cardiology
[Accumetrics, VerifyNow, antiplatelet agents, clopidogrel]
|
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
HSMN NewsFeed,
12 Mar 2010:
Biopharmaceuticals, Personnel
[Endo Pharmaceuticals]
|
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development
HSMN NewsFeed,
1 Mar 2010:
Regenerative Medicine, Personnel
[Garnet BioTherapeutics]
|
Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer
HSMN NewsFeed,
1 Mar 2010:
Biopharmaceuticals, Drug Delivery, Personnel
[Transdel Pharmaceuticals, Ketotransdel]
|
Centocor Ortho Biotech Products and Amgen Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
HSMN NewsFeed,
16 Feb 2010:
Biopharmaceuticals, Oncology, FDA
[Centocor Ortho Biotech, Amgen, erythropoiesis, EPOGEN, Aranesp, Procrit]
|
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
HSMN NewsFeed,
9 Feb 2010:
Biopharmaceuticals, Personnel
[Xencor]
|
Human Genome Sciences Names Scott Habig Vice President, Sales
HSMN NewsFeed,
1 Feb 2010:
Biopharmaceuticals, Personnel
[Human Genome Sciences]
|
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
HSMN NewsFeed,
25 Jan 2010:
Biopharmaceuticals, Oncology
[Bristol-Myers Squibb, Centocor Ortho Biotech, NCCN, Taxol, Doxil, ovarian cancer]
|
STELARA(TM) (ustekinumab) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
14 Jan 2010:
Biopharmaceuticals, Dermatology
[Janssen-Cilag, Johnson & Johnson, STELARA, ustekinumab, psoriasis]
|
Intuity Medical Closes $64 Million Series D Financing - One of the Largest Medical Device Funding Events of 2009
HSMN NewsFeed,
5 Jan 2010:
Devices, Monitoring, Endocrinology, Venture Capital
[Intuity Medical, glucose monitor, diabetes]
|
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)
HSMN NewsFeed,
25 Nov 2009:
Biopharmaceuticals, HIV/AIDS, FDA
[Tibotec Therapeutics, Centocor Ortho Biotech, INTELENCE, etravirine]
|
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
HSMN NewsFeed,
24 Nov 2009:
Biopharmaceuticals, Personnel
[NeurogesX, Qutenza, capsaicin]
|
Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody
HSMN NewsFeed,
28 Oct 2009:
Biopharmaceuticals, Licensing
[Morphotek, Eisai, Centocor Ortho Biotech, Monoclonal Antibody]
|
New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis
HSMN NewsFeed,
19 Oct 2009:
Biopharmaceuticals
[Centocor Ortho Biotech, Schering-Plough, SIMPONI, golimumab, arthritis]
|
New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis
HSMN NewsFeed,
19 Oct 2009:
Biopharmaceuticals
[Centocor Ortho Biotech, Schering-Plough, SIMPONI, golimumab, arthritis]
|
SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector
HSMN NewsFeed,
6 Oct 2009:
Biopharmaceuticals, Regulatory
[Schering-Plough, Centocor Ortho Biotech, SIMPONI, golimumab]
|
Janssen-Cilag's STELARA(R) (Black Triangle Drug) (ustekinumab) Approved by NICE for the Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
23 Sep 2009:
Biopharmaceuticals, Dermatology, Regulatory
[Janssen-Cilag, STELARA, ustekinumab, psoriasis, Black Triangle Drug]
|
Lilly Names New Business Leaders
HSMN NewsFeed,
14 Sep 2009:
Biopharmaceuticals, Personnel
[Eli Lilly]
|
FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL
HSMN NewsFeed,
10 Sep 2009:
Biopharmaceuticals, Oncology, FDA
[Centocor, Ortho Biotech, trabectedin, ovarian cancer]
|
Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer
HSMN NewsFeed,
15 Jul 2009:
Biopharmaceuticals, Oncology, FDA
[Centocor Ortho Biotech, Johnson & Johnson, trabectedin, ovarian cancer]
|
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
HSMN NewsFeed,
3 Jul 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Johnson & Johnson, Cougar Biotechnology]
|
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
HSMN NewsFeed,
30 Jun 2009:
Biopharmaceuticals
[Catalyst Biosciences, Wyeth Pharmaceuticals, Factor VIIa, hemophilia]
|
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
HSMN NewsFeed,
26 Jun 2009:
Biopharmaceuticals, Regulatory
[Schering-Plough, Centocor Ortho Biotech, SIMPONI, golimumab]
|
Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
HSMN NewsFeed,
27 May 2009:
Diagnostics, Cardiology, Distribution
[Accumetrics, VerifyNow, GP IIb/IIIa, antiplatelet]
|
Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
HSMN NewsFeed,
21 May 2009:
Biopharmaceuticals, Oncology, Mergers & Acquisitions
[Johnson & Johnson, Cougar Biotechnology]
|
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
HSMN NewsFeed,
24 Apr 2009:
Biopharmaceuticals, FDA
[Centocor Ortho Biotech, SIMPONI, golimumab, rheumatoid arthritis]
|
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
HSMN NewsFeed,
27 Feb 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Cephalon, Arana Therapeutics]
|
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
HSMN NewsFeed,
26 Feb 2009:
Devices, Diagnostics, Personnel
[Accumetrics, VerifyNow, antiplatelet]
|
PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
HSMN NewsFeed,
11 Feb 2009:
Biopharmaceuticals, HIV/AIDS
[Tibotec Therapeutics, Johnson & Johnson, PREZISTA, darunavir]
|
Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine)
HSMN NewsFeed,
5 Feb 2009:
Biopharmaceuticals
[Tibotec, Centocor Ortho Biotech Products, INTELENCE, etravirine, DUET-1, DUET-2]
|
New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
22 Jan 2009:
Biopharmaceuticals, Regulatory
[Janssen-Cilag, STELARA, ustekinumab, severe plaque psoriasis, psoriasis]
|
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
HSMN NewsFeed,
10 Dec 2008:
Biopharmaceuticals, Personnel
[MorphoSys]
|
Catalyst Biosciences Raises $40 Million in Series C Financing
HSMN NewsFeed,
3 Dec 2008:
Biopharmaceuticals, Venture Capital
[Catalyst Biosciences, Alterase]
|
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
HSMN NewsFeed,
26 Nov 2008:
Biopharmaceuticals
[MorphoSys, Galapagos NV, antibodies, arthritis]
|
Awarepoint Corporation Closes $13.3 M Series D Financing Round
HSMN NewsFeed,
25 Nov 2008:
Devices, Venture Capital
[Awarepoint]
|
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
HSMN NewsFeed,
4 Nov 2008:
Diagnostics, Cardiology, Personnel
[Accumetrics, VerifyNow, antiplatelet, Plavix, ReoPro, Integrilin]
|
Timothy I. Still Appointed CEO at Accumetrics
HSMN NewsFeed,
30 Oct 2008:
Diagnostics, Personnel
[Accumetrics]
|
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
HSMN NewsFeed,
30 Oct 2008:
Biopharmaceuticals, Venture Capital
[Alnara Pharmaceuticals]
|
One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
HSMN NewsFeed,
27 Oct 2008:
Biopharmaceuticals
[Centocor, golimumab, psoriatic arthritis]
|
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
HSMN NewsFeed,
23 Sep 2008:
Biopharmaceuticals, Personnel
[Cook Medical, Cook Pharmica]
|
Findings From Landmark Study Show Ustekinumab Demonstrated Superior Efficacy to Enbrel(R) (Etanercept) in Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
18 Sep 2008:
Biopharmaceuticals, Dermatology
[Centocor, ustekinumab, etanercept, Enbrel, Psoriasis]
|
FDA Extends Review Timeline for Ustekinumab Biologic License Application Three Months
HSMN NewsFeed,
8 Aug 2008:
Biopharmaceuticals, FDA
[Centocor, ustekinumab, psoriasis]
|
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals, Personnel
[Royalty Pharma]
|
Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
HSMN NewsFeed,
27 Jun 2008:
Biopharmaceuticals
[Centocor, golimumab, CNTO 148, rheumatoid arthritis, psoriatic arthritis]
|
FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
17 Jun 2008:
Biopharmaceuticals, Dermatology
[Centocor, ustekinumab, psoriasis]
|
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
HSMN NewsFeed,
16 Jun 2008:
Biopharmaceuticals, Oncology, Licensing
[MorphoSys AG, OncoMed Pharmaceuticals, cancer stem cells]
|
Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
HSMN NewsFeed,
11 Jun 2008:
Biopharmaceuticals
[Centocor, golimumab, rheumatoid arthritis, tumor necrosis factor]
|
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
HSMN NewsFeed,
11 Jun 2008:
Biopharmaceuticals, Oncology
[Centocor, golimumab, rheumatoid arthritis]
|
Affymax(R) Announces Executive Management Promotions
HSMN NewsFeed,
4 Jun 2008:
Biopharmaceuticals, Personnel
[Affymax]
|
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
HSMN NewsFeed,
9 May 2008:
Biopharmaceuticals, Personnel
[Celator Pharmaceuticals]
|
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
HSMN NewsFeed,
3 Apr 2008:
Biopharmaceuticals, Personnel
[Alba Therapeutics]
|
Discovery Labs Adds Two Executives to Its Management Team
HSMN NewsFeed,
27 Mar 2008:
Biopharmaceuticals, Personnel
[Discovery Laboratories]
|
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
HSMN NewsFeed,
18 Mar 2008:
Biopharmaceuticals, Regulatory
[Centocor, Schering-Plough, golimumab, rheumatoid arthritis, psoriatic arthritis]
|
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
HSMN NewsFeed,
12 Mar 2008:
Biopharmaceuticals, Personnel
[Endo Pharmaceuticals]
|
Trevena, Inc. Announces $24 Million Series A Financing
HSMN NewsFeed,
5 Mar 2008:
Biopharmaceuticals, Venture Capital
[Trevena, G-protein coupled receptors]
|
Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals, Dermatology, FDA
[Centocor, ustekinumab, psoriasis]
|
Promedior Adds to Management Team and Announces Extension of Series A Financing
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals, Personnel, Venture Capital
[Promedior]
|
Medivation Names Rohan Palekar Chief Commercial Officer
HSMN NewsFeed,
15 Jan 2008:
Biopharmaceuticals, Personnel
[Medivation]
|
Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
HSMN NewsFeed,
21 Dec 2007:
Biopharmaceuticals, Distribution
[Schering-Plough, Centocor, REMICADE, infliximab, golimumab]
|
Heartscape Technologies Appoints Former Medtronic Executive to Role as Chairman and Independent Director
HSMN NewsFeed,
11 Dec 2007:
Devices, Personnel
[Heartscape Technologies]
|
Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed,
4 Dec 2007:
Biopharmaceuticals, FDA, Regulatory
[Centocor, Janssen-Cilag, stekinumab, psoriasis]
|
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed,
27 Nov 2007:
Biopharmaceuticals, Personnel
[Neuromed Pharmaceuticals]
|
Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals
[Centocor, psoriatic arthritis, golimumab, anti-tumor necrosis factor]
|
New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms Of Ankylosing Spondylitis According to Phase 3 Study Findings
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals
[Centocor, golimumab, ankylosing spondylitis, anti-tumor necrosis factor]
|
REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
HSMN NewsFeed,
6 Nov 2007:
Biopharmaceuticals
[Centocor, Schering-Plough, Mitsubishi Tanabe Pharma, REMICADE, infliximab]
|
MedImmune Announces Seven Key Promotions and New Hires
HSMN NewsFeed,
5 Nov 2007:
Biopharmaceuticals, Personnel
[MedImmune]
|
Xencor Expands Series E Financing to $60 Million
HSMN NewsFeed,
25 Oct 2007:
Biopharmaceuticals, Venture Capital
[Xencor, XmAb]
|
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer
HSMN NewsFeed,
25 Oct 2007:
Biopharmaceuticals, Personnel
[Xencor]
|
Clinical Studies Show REMICADE Reduces Incidence of Bowel Surgeries in Ulcerative Colitis Patients
HSMN NewsFeed,
15 Oct 2007:
Biopharmaceuticals, Gastroenterology
[Centocor, REMICADE, infliximab, ulcerative colitis]
|
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
HSMN NewsFeed,
4 Oct 2007:
Biopharmaceuticals, Personnel
[Hyperion Therapeutics]
|
Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
HSMN NewsFeed,
3 Oct 2007:
Biopharmaceuticals, Dermatology
[Centocor, ustekinumab, CNTO 1275, psoriasis]
|
NeurogesX Appoints New Director to the Board
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals, Personnel
[NeurogesX]
|
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals
[Medarex, UltiMAb, Centocor]
|
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
HSMN NewsFeed,
14 Aug 2007:
Biopharmaceuticals, Personnel
[Affymax]
|
ImClone Systems Appoints John H. Johnson Chief Executive Officer
HSMN NewsFeed,
9 Aug 2007:
Biopharmaceuticals, Personnel
[ImClone Systems]
|
REMICADE(R) Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation
HSMN NewsFeed,
15 Jun 2007:
Biopharmaceuticals
[Schering-Plough, Centocor, ankylosing spondylitis, REMICADE, infliximab]
|
Critical Biologics Appoints Chief Medical Officer
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals, Personnel
[Critical Biologics Corporation]
|
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
HSMN NewsFeed,
7 Jun 2007:
Biopharmaceuticals, Gastroenterology, Regulatory
[Schering-Plough, Centocor, REMICADE, infliximab, Crohn's disease]
|
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, Oncology
[Abbott, Caprion Proteomics, Thallion Pharmaceuticals, CellCarta]
|
BrainCells Names Seth D. Goldblum VP, Business Development
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Neurology, Personnel
[BrainCells]
|
Royalty Pharma Acquires a Portion of New York University's Royalty Interest in Remicade(R) for $650 Million
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals
[Royalty Pharma, Remicade]
|
European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
HSMN NewsFeed,
26 Mar 2007:
Biopharmaceuticals, Regulatory, Gastroenterology
[Schering-Plough, Centocor, REMICADE, infliximab, Crohn's disease]
|
ImmunoGen, Inc. Announces Departure of Walter Blattler
HSMN NewsFeed,
6 Mar 2007:
Biopharmaceuticals, Personnel
[ImmunoGen]
|
Alkermes Announces Senior Management Succession Plan
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Personnel
[Alkermes]
|
Immunotope, Inc. Announces Board and Management Appointments
HSMN NewsFeed,
2 Mar 2007:
Biopharmaceuticals, Personnel
[Immunotope]
|
MedImmune Further Expands its Commercial Organization Expertise With Appointment of Two Additional Vice Presidents
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Personnel
[MedImmune]
|
Labopharm appoints Vice President Sales and Marketing
HSMN NewsFeed,
15 Feb 2007:
Biopharmaceuticals, Personnel
[Labopharm]
|
New Analyses Reinforce Efficacy of REMICADE(R) in Treatment of Severe Psoriasis
HSMN NewsFeed,
2 Feb 2007:
Biopharmaceuticals, Dermatology
[Centocor, REMICADE, infliximab, psoriasis]
|
REMICADE(R) Therapy Shown to Improve Productivity in Patients Treated for Chronic Plaque Psoriasis
HSMN NewsFeed,
2 Feb 2007:
Biopharmaceuticals, Dermatology
[Centocor, plaque psoriasis, psoriasis, REMICADE, infliximab]
|
Xencor Appoints Jade R. Brown as Vice President of Business Development
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals, Personnel
[Xencor]
|
Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn's Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
HSMN NewsFeed,
8 Jan 2007:
Regenerative Medicine, Gastroenterology
[Osiris Therapeutics, fast track designation, Crohn's Disease, PROCHYMAL]
|
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
HSMN NewsFeed,
26 Dec 2006:
Biopharmaceuticals, Drug Delivery, Licensing
[ImmunoGen, Tumor-Activated Prodrug, sanofi-aventis]
|
Curis Announces Key Management Promotions
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals, Personnel
[Curis]
|
Adolor Elects Michael R. Dougherty Chief Executive Officer
HSMN NewsFeed,
14 Dec 2006:
Biopharmaceuticals, Personnel
[Adolor, Entereg, alvimopan, postoperative ileus]
|
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Personnel
[Ambit Biosciences]
|
Urigen N.A., Inc. Appoints Terry M. Nida to Chief Operating Officer
HSMN NewsFeed,
29 Nov 2006:
Biopharmaceuticals, Personnel
[Urigen , Valentis]
|
Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & Operations
HSMN NewsFeed,
8 Nov 2006:
Biopharmaceuticals, Personnel
[Halozyme Therapeutics]
|
Data Show Treatment With Remicade(R) Reduced Hospitalizations for Ulcerative Colitis Patients By Half
HSMN NewsFeed,
23 Oct 2006:
Biopharmaceuticals, Gastroenterology
[Centocor, REMICADE, infliximab, ulcerative colitis]
|
Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) in Treatment-Resistant Crohn's Disease
HSMN NewsFeed,
19 Oct 2006:
Biopharmaceuticals, Gastroenterology
[Osiris Therapeutics, PROCHYMAL, Crohn's disease, stem cell therapy]
|
FDA Expands REMICADE(R) Indication for Ulcerative Colitis: Biologic Maintains Long-Term Clinical Remission and Mucosal Healing
HSMN NewsFeed,
19 Oct 2006:
Biopharmaceuticals, Gastroenterology, FDA
[Centocor, REMICADE, infliximab, ulcerative colitis]
|
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
HSMN NewsFeed,
16 Oct 2006:
Biopharmaceuticals
[NEUROCHEM, KIACTA, eprodisate, FIBRILLEX, AA amyloidosis]
|
Curis, Inc. Announces Genentech Filing of Investigational New Drug Application for Systemic Administration of a Hedgehog Antagonist
HSMN NewsFeed,
5 Oct 2006:
Biopharmaceuticals
[Curis , Genentech, Hedgehog]
|
Curis, Inc. Agrees to Settlement with Micromet AG
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Litigation
[Micromet , Curis]
|
FDA Approves REMICADE(R) for Treatment of Chronic Severe Plaque Psoriasis: Marks Major Milestone for Patients With High Disease Burden
HSMN NewsFeed,
27 Sep 2006:
Biopharmaceuticals, FDA
[Centocor, REMICADE, infliximab, Severe Plaque Psoriasis]
|
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
HSMN NewsFeed,
12 Sep 2006:
Biopharmaceuticals
[Curis]
|
Curis Determines to Opt Out of Co-Development of Basal Cell Carcinoma Drug Candidate
HSMN NewsFeed,
1 Sep 2006:
Biopharmaceuticals
[Curis, Genentech, basal cell carcinoma]
|
Sapphire Therapeutics, Inc. Expands Drug Development Team
HSMN NewsFeed,
25 Aug 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
Kemia Closes Series C Financing
HSMN NewsFeed,
23 Aug 2006:
Biopharmaceuticals, Venture Capital
[ Kemia]
|
Schering-Plough Receives Clarification of Its Rights for Golimumab
HSMN NewsFeed,
17 Aug 2006:
Biopharmaceuticals
[Schering-Plough, Centocor, golimumab]
|
Altus Pharmaceuticals Appoints Renato Fuchs, Ph.D., Senior Vice President, Manufacturing and Technical Operations
HSMN NewsFeed,
17 Aug 2006:
Biopharmaceuticals, Personnel
[Altus Pharmaceuticals]
|
FDA Expands REMICADE(R) Psoriatic Arthritis Indication: Anti-TNF Shown to Inhibit Joint Damage and Improve Physical Function
HSMN NewsFeed,
14 Aug 2006:
Biopharmaceuticals, FDA
[Centocor, REMICADE, infliximab, psoriatic arthritis]
|
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
HSMN NewsFeed,
11 Jul 2006:
Biopharmaceuticals, Licensing
[ImmunoGen, Biotest AG, Tumor-Activated Prodrug]
|
FDA Accepts REMICADE(R) Supplemental Biologics License Application for Inhibition of Structural Damage and Improving Physical Function in Patients With Psoriatic Arthritis
HSMN NewsFeed,
21 Jun 2006:
Biopharmaceuticals, FDA
[Centocor, REMICADE, infliximab, psoriatic arthritis]
|
ViaCell Announces Cardiac Collaboration with Centocor Research and Development, Inc.
HSMN NewsFeed,
13 Jun 2006:
Regenerative Medicine, Cardiology
[ViaCell, Stem Cell Internal Venture, Centocor, Cordis]
|
Ablynx Strengthens Management Team - Eva-Lotta Allan Joins as Chief Business Officer
HSMN NewsFeed,
1 Jun 2006:
Biopharmaceuticals, Personnel
[Ablynx]
|
Fujirebio Diagnostics Acquires CanAg Diagnostics
HSMN NewsFeed,
31 May 2006:
Diagnostics, Mergers & Acquisitions
[Fujirebio Diagnostics, CanAg Diagnostics]
|
New Analysis Showed Ulcerative Colitis Patients in Clinical Remission Had Higher Rates of Employment and Lower Rates of Disability
HSMN NewsFeed,
24 May 2006:
Biopharmaceuticals, Gastroenterology
[Centocor, REMICADE, infliximab, Ulcerative Colitis]
|
Topical Hedgehog Agonist Accelerates Wound Healing in Diabetes
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals, Wound Care
[ Curis, Sonic Hedgehog, gene therapy]
|
MedImmune Fills Senior Marketing and Sales Post
HSMN NewsFeed,
22 May 2006:
Biopharmaceuticals, Personnel
[MedImmune, Peter S. Greenleaf]
|
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
HSMN NewsFeed,
22 May 2006:
Biopharmaceuticals, Personnel
[Xanthus Pharmaceuticals]
|
MorphoSys and Schering-Plough Sign R&D Agreement
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals
[MorphoSys , Schering-Plough, Combinatorial Antibody Library, HuCAL]
|
YM Biosciences completes acquisition of Eximias
HSMN NewsFeed,
9 May 2006:
Biopharmaceuticals, Oncology, Mergers & Acquisitions
[YM BioSciences, Eximias Pharmaceutical]
|
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals
[ImmunoGen, Genentech]
|
Othera Pharmaceuticals Elects Katherine Crothall and Bruce Peacock to Board
HSMN NewsFeed,
3 May 2006:
Biopharmaceuticals, Personnel
[Othera Pharmaceuticals]
|
Neurochem announces eprodisate (Fibrillex(TM)) NDA filed and granted priority review by FDA for the treatment of AA amyloidosis
HSMN NewsFeed,
18 Apr 2006:
Biopharmaceuticals, Neurology, FDA
[Neurochem , Fibrillex, eprodisate, Amyloid A, amyloidosis]
|
Biolex Therapeutics Announces Expansion of Medarex Collaboration
HSMN NewsFeed,
11 Apr 2006:
Biopharmaceuticals
[Biolex Therapeutics, Medarex, monoclonal antibody]
|
FDA Grants Priority Review of REMICADE(R) for the Treatment of Children with Active Crohn's Disease
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, Gastroenterology, FDA
[Centocor, REMICADE, infliximab, Crohn's disease]
|
REMICADE(R) Is Approved in Australia for Treatment of Early Rheumatoid Arthritis and Psoriatic Arthritis
HSMN NewsFeed,
23 Mar 2006:
Biopharmaceuticals, Regulatory
[Schering-Plough, REMICADE, infliximab, rheumatoid arthritis]
|
La Jolla Pharmaceutical Announces Appointment of Deirdre Y. Gillespie as New Chief Executive Officer
HSMN NewsFeed,
15 Mar 2006:
Biopharmaceuticals, Personnel
[La Jolla Pharmaceutical]
|
REMICADE(R) Is First Biologic Approved In European Union To Treat Ulcerative Colitis
HSMN NewsFeed,
9 Mar 2006:
Biopharmaceuticals, Gastroenterology, Regulatory
[Schering-Plough, Centocor, REMICADE, infliximab, ulcerative colitis]
|
REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement and Long-Term Response in the Treatment of Moderate to Severe Psoriasis
HSMN NewsFeed,
6 Mar 2006:
Biopharmaceuticals
[Centocor, REMICADE, infliximab, psoriasis, EXPRESS II trial]
|
REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement and Long-Term Response in the Treatment of Moderate to Severe Psoriasis
HSMN NewsFeed,
3 Mar 2006:
Biopharmaceuticals, Dermatology
[Centocor, REMICADE, tumor necrosis factor, psoriasis]
|
Neurochem submits NDA for Fibrillex(TM)
HSMN NewsFeed,
13 Feb 2006:
Biopharmaceuticals, FDA
[NEUROCHEM , eprodisate, Fibrillex, AA amyloidosis]
|
European Union CHMP Recommends Approval of REMICADE(R) for Treatment of Moderately to Severely Active Ulcerative Colitis
HSMN NewsFeed,
30 Jan 2006:
Biopharmaceuticals, Gastroenterology, Regulatory
[Schering-Plough, REMICADE, infliximab, ulcerative colitis]
|
ViroPharma Broadens Senior Management
HSMN NewsFeed,
19 Jan 2006:
Biopharmaceuticals, Personnel
[ViroPharma]
|
Genentech Announces Vice President Appointments in Commercial Operations, Corporate Information Technology, Product Development and Product Operations
HSMN NewsFeed,
9 Jan 2006:
Biopharmaceuticals, Personnel
[Genentech]
|
|
|
 |
Additional items found:
The Network Archive contains
128 additional items
matching: Centocor
<< Members - click the icon at left to display. |
|
| |
|
|
|
|
Public
Feeds 
Full text >>